“Overview of Available Treatment and New Drug Action Points in Obesity Pharmacology. Will GIP, Glucagon, Amylin Replace GLP-1?”. Prospects in Pharmaceutical Sciences 23, no. 2 (May 6, 2025): 42–49. Accessed November 9, 2026. https://prospects.wum.edu.pl/index.php/pps/article/view/361.